Literature DB >> 20878255

Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular volumes and ejection fraction in patients with idiopathic dilated cardiomyopathy.

Petri Sipola1, Keijo Peuhkurinen, Esko Vanninen.   

Abstract

To prospectively compare the left ventricular end-diastolic volume (LVEDV), end-systolic volume (LVESV), and ejection fraction (LVEF) obtained from gated perfusion single photon emission computed tomography (GSPECT) with those obtained from cardiac magnetic resonance imaging (MRI) in patients with idiopathic dilated cardiomyopathy (IDC). Twenty-one patients with IDC (6 females) with a median age of 45 years (range 17-65) were scheduled for (99m)Tc-tetrofosmin-GSPECT and MRI within a 3 h interval. In both methods LV volumes were analyzed with the Simpson method. Both GSPECT and MRI were successfully completed in 90% of patients. Close linear correlations were observed between the two methods in LVEDV (R = 0.918; P < 0.001) and LVESV (R = 0.946; P < 0.001), but correlations were significantly weaker in LVEF (R = 0.323; P = 0.082). LVEDV and LVESV were smaller in GSPECT than in MRI (161 ± 73 vs. 214 ± 87 ml, P < 0.001, and 116 ± 64 vs. 138 ± 72 ml, P < 0.001, respectively). In 4 patients (21%) the LVEDV index was considered normal by GSPECT and increased by MRI, if MRI-derived normal values were used. No difference was found between GSPECT and MRI when LVEF(MRI) was ≤ 40%, but GSPECT showed smaller LVEF when LVEF(MRI) was over 40% (33 ± 11 vs. 50 ± 5%; P < 0.05). The finding of increased LVEDV in GSPECT is reliable compared with MRI. However, LV volumes were underestimated by GSPECT and no direct comparisons can be made between methods in follow up studies. Abnormal results should be confirmed by another imaging modality, such as MRI, if these findings have therapeutic consequences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878255     DOI: 10.1007/s10554-010-9702-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

1.  Evaluation of left ventricular wall motion, volumes, and ejection fraction by gated myocardial tomography with technetium 99m-labeled tetrofosmin: a comparison with cine magnetic resonance imaging.

Authors:  P Vaduganathan; Z X He; G W Vick; J J Mahmarian; M S Verani
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis.

Authors:  John P A Ioannidis; Thomas A Trikalinos; Peter G Danias
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

3.  Validation of 4D-MSPECT and QGS for quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPET: comparison with cardiac magnetic resonance imaging.

Authors:  Claudia S A Lipke; Harald P Kühl; Bernd Nowak; Hans-Juergen Kaiser; Patrick Reinartz; Karl-Christian Koch; Udalrich Buell; Wolfgang M Schaefer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

Review 4.  Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.

Authors:  Dudley J Pennell; Udo P Sechtem; Charles B Higgins; Warren J Manning; Gerald M Pohost; Frank E Rademakers; Albert C van Rossum; Leslee J Shaw; E Kent Yucel
Journal:  Eur Heart J       Date:  2004-11       Impact factor: 29.983

5.  Normal limits of ejection fraction and volumes determined by gated SPECT in clinically normal patients without cardiac events: a study based on the J-ACCESS database.

Authors:  Kenichi Nakajima; Hideo Kusuoka; Shigeyuki Nishimura; Akira Yamashina; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-12       Impact factor: 9.236

6.  Factors predicting mortality in idiopathic dilated cardiomyopathy.

Authors:  M Komajda; J P Jais; F Reeves; B Goldfarb; J B Bouhour; Y Juillieres; J Lanfranchi; P Peycelon; P Geslin; D Carrie
Journal:  Eur Heart J       Date:  1990-09       Impact factor: 29.983

7.  Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.

Authors:  Shu Kasama; Takuji Toyama; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Shoichi Tange; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-11       Impact factor: 10.057

8.  Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis.

Authors:  C S Rihal; R A Nishimura; L K Hatle; K R Bailey; A J Tajik
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

9.  Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.

Authors:  Pekka Timonen; Jarkko Magga; Juha Risteli; Kari Punnonen; Esko Vanninen; Anu Turpeinen; Petri Tuomainen; Johanna Kuusisto; Olli Vuolteenaho; Keijo Peuhkurinen
Journal:  Int J Cardiol       Date:  2007-04-17       Impact factor: 4.164

10.  Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy.

Authors:  Peter G Danias; Georgios I Papaioannou; Alan W Ahlberg; David M O'Sullivan; April Mann; William E Boden; Gary V Heller
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

View more
  2 in total

Review 1.  Cardiovascular imaging 2011 in the International Journal of Cardiovascular Imaging.

Authors:  Ricardo A Costa; Hiram G Bezerra; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2012-03       Impact factor: 2.357

2.  The role of imaging in the management of cardiorenal syndrome.

Authors:  Sajid Melvin George; Kambiz Kalantarinia
Journal:  Int J Nephrol       Date:  2011-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.